Purpose
Edited by: Gedis Grudzinskas, Independent Researcher, London, United KingdomReviewed by: Jaana Seikkula, Central Finland Central Hospital, Finland; Loris Marin, University of Padua, Italy†These authors share first authorshipThis randomised clinical pilot study evaluated the effect of the mid-luteal additional single dose of gonadotropin-releasing hormone agonist (GnRH-a) on the clinical outcome of the females subjected to artificial cycle frozen-thawed embryo transfer (AC-FET).